SIMILAR OVARIAN RESPONSE WITH INDIVIDUALIZED FOLLITROPIN DELTA DOSING REGIMEN IN JAPANESE AND NON-JAPANESE IVF/ICSI PATIENTS.

被引:0
|
作者
Ishihara, Osamu [1 ]
Andersen, Anders Nyboe [2 ]
Nelson, Scott M. [3 ]
Arce, Joan-Carles [4 ]
机构
[1] Saitama Med Univ, Saitama, Japan
[2] Rigshosp, Copenhagen, Denmark
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Ferring Pharmaceut, Copenhagen, Denmark
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-443
引用
收藏
页码:E286 / E287
页数:2
相关论文
共 18 条
  • [1] SIMILAR DOSE-RESPONSE PROFILES FOR FOLLITROPIN DELTA IN JAPANESE AND NON-JAPANESE IVF/ICSI PATIENTS.
    Ishihara, Osamu
    Arce, Joan-Carles
    FERTILITY AND STERILITY, 2020, 114 (03) : E293 - E293
  • [2] Comparison of ovarian response to follitropin delta in Japanese and White IVF/ICSI patients
    Ishihara, Osamu
    Nelson, Scott M.
    Arce, Joan-Carles
    REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 44 (01) : 177 - 184
  • [3] Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF/ICSI patients: a randomized controlled trial
    Ishihara, Osamu
    Arce, Joan-Cartes
    REPRODUCTIVE BIOMEDICINE ONLINE, 2021, 42 (05) : 909 - 918
  • [4] REDUCTION IN OHSS INCIDENCE IN JAPANESE IVF/ICSI PATIENTS WHEN APPLYING INDIVIDUALIZED DOSING WITH FOLLITROPIN DELTA.
    Ishihara, Osamu
    Arce, Joan-Carles
    FERTILITY AND STERILITY, 2020, 114 (03) : E457 - E457
  • [5] A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF/ICSI patients
    Qiao, Jie
    Zhang, Yunshan
    Liang, Xiaoyan
    Ho, Tuong
    Huang, Hong-Yuan
    Kim, Sung-Hoon
    Goethberg, Marie
    Mannaerts, Bernadette
    Arce, Joan-Carles
    HUMAN REPRODUCTION, 2021, 36 (09) : 2452 - 2462
  • [6] A randomised, assessor-blind, controlled phase 3 non-inferiority trial assessing the efficacy and safety of individualised follitropin delta dosing regimen in Japanese IVF/ICSI patients
    Ishihara, O.
    Kitamura, M.
    Arce, J. C.
    HUMAN REPRODUCTION, 2020, 35 : I397 - I397
  • [7] A randomised, assessor-blind, AMH-stratified, dose-response trial in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation with follitropin delta
    Ishihara, O.
    Arce, J. C.
    HUMAN REPRODUCTION, 2017, 32 : 444 - 444
  • [8] Interferon Gene Signature Expression and Serological Differences in Japanese and Non-Japanese SLE Patients.
    Kohsaka, Hitoshi
    Kotani, Kosuke
    Ishii, Tomonori
    Miyamura, Tomoya
    Okada, Masato
    Aranishi, Toshihiko
    Maciuca, R.
    Kennedy, William P.
    Ohata, Junko
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S725 - S725
  • [9] ABSENCE OF ETHNIC DIFFERENCES IN PHARMACOKINETIC PROFILE OF ENFORTUMAB VEDOTIN BETWEEN JAPANESE AND NON-JAPANESE PATIENTS.
    Yamada, A.
    Fukushi, R.
    Kadokura, T.
    Garg, A.
    Tang, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S58 - S58
  • [10] Migalastat exposures in Japanese healthy volunteers and non-Japanese subjects provide evidence that they are similar to Japanese patients with Fabry disease
    Johnson, Franklin K.
    Ohashi, Toya
    Yang, Linda
    Yu, Julie
    Skuban, Nina
    Castelli, Jeffrey
    Barth, Jay
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S71 - S72